Merck’s Lipid-Lowering Combo Cordaptive Could Clear FDA In Mid-2008
This article was originally published in The Pink Sheet Daily
Executive Summary
The company announced it has filed the niacin and laropiprant combination, formerly known as MK-0524A.
You may also be interested in...
Abbott Won’t Shrink From Competitor Merck’s Cordaptive
Merck’s niacin/laropiprant combination will compete against Abbott’s Niaspan after it is approved by FDA.
Abbott Won’t Shrink From Competitor Merck’s Cordaptive
Merck’s niacin/laropiprant combination will compete against Abbott’s Niaspan after it is approved by FDA.
Merck Freezes Cordaptive ACHIEVE Trial
Imaging endpoint stalls cholesterol study, per a monitoring panel’s advice.